Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through the Pharmaceutical Benefits Scheme (PBS)—there is both a strong moral and ...

The Rahway, N.J., drug maker said Friday that its treatment, Keytruda, has been approved for adult patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...

The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Merck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is ...

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

Martin Kulldorff, appointed by RFK Jr. to a federal vaccine panel, previously earned $33K as an expert witness in lawsuits ...

Health and Human Services Secretary Robert F. Kennedy, Jr., has announced new members of the Centers for Disease Control and Prevention’s vaccine advisory panel. At such a critical moment in US ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...